Soleno Therapeutics, Inc. (SLNO)
42.48
+0.53
(+1.26%)
USD |
NASDAQ |
Jan 16, 16:00
42.72
+0.24
(+0.56%)
After-Hours: 20:00
Soleno Therapeutics Shareholders Equity (Quarterly): 494.80M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AVITA Medical, Inc. | -6.666M |
| Agilon Health, Inc. | 306.08M |
| Nektar Therapeutics | 85.09M |
| Rigel Pharmaceuticals, Inc. | 117.61M |
| Marker Therapeutics, Inc. | 18.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 599.90M |
| Total Liabilities (Quarterly) | 105.09M |
| Debt to Equity Ratio | 0.1064 |
| Current Ratio | 16.08 |
| Net Debt Paydown Yield | -0.29% |